(Translated by https://www.hiragana.jp/)
ORG-2058 - Wikipedia Jump to content

ORG-2058

From Wikipedia, the free encyclopedia
ORG-2058
Clinical data
Other names16αあるふぁ-Ethyl-21-hydroxy-19-norprogesterone; 16αあるふぁ-Ethyl-21-hydroxy-19-norpregn-4-ene-3,20-dione
Identifiers
  • (8R,9S,10R,13S,14S,16R,17S)-16-ethyl-17-(2-hydroxyacetyl)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC22H32O3
Molar mass344.495 g·mol−1
3D model (JSmol)
  • CC[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]2([C@H]1C(=O)CO)C
  • InChI=1S/C22H32O3/c1-3-13-11-19-18-6-4-14-10-15(24)5-7-16(14)17(18)8-9-22(19,2)21(13)20(25)12-23/h10,13,16-19,21,23H,3-9,11-12H2,1-2H3/t13-,16+,17-,18-,19+,21-,22+/m1/s1
  • Key:IJLXLZGJDSJGIQ-BILPMHSYSA-N

ORG-2058, also known as 16αあるふぁ-ethyl-21-hydroxy-19-norprogesterone, is a progestin of the 19-norprogesterone group which was never marketed.[1][2] It has high affinity for the progesterone receptor (775% of that of progesterone) and has been used in scientific research to study the role of the progesterone receptor in the body.[2] The drug has no affinity for the estrogen receptor or the glucocorticoid receptor (less than 0.2% of the affinities of estradiol and dexamethasone, respectively)[3] and has slight affinity for the mineralocorticoid receptor, but less than that of progesterone.[4]

See also

[edit]

References

[edit]
  1. ^ Negwer M, Scharnow HG (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 2350. ISBN 978-3-527-30247-5.
  2. ^ a b Fleischmann G, Beato M (1978). "Characterization of the progesterone receptor of rabbit uterus with the synthetic progestin 16αあるふぁ-ethyl-21-hydroxy-19-norpregn-4-ene-3,20-dione". Biochimica et Biophysica Acta (BBA) - General Subjects. 540 (3): 500–517. doi:10.1016/0304-4165(78)90180-0. ISSN 0304-4165.
  3. ^ Bergink EW, Loonen PB, Kloosterboer HJ (August 1985). "Receptor binding of allylestrenol, a progestagen of the 19-nortestosterone series without androgenic properties". Journal of Steroid Biochemistry. 23 (2): 165–168. doi:10.1016/0022-4731(85)90232-8. PMID 3928974.
  4. ^ Thompson EB, Lippman ME (1979). Steroid receptors and the management of cancer. CRC Press. ISBN 978-0-8493-5477-9. Org 2058 competed slightly, but less than progesterone, for mineralocorticoid binding.
Stub icon

This article about a steroid is a stub. You can help Wikipedia by expanding it.

Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=ORG-2058&oldid=1169453685"